Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells
AssigneesCharles S. Cobbs, Luaihati Harkins
InventorsCharles S. Cobbs, Lualhatil E. Harkins
Life of this patent
Estimating the term…
Abstract
The present disclosure shows human cytomegalovirus (HCMV) is strongly associated with a variety of cancers in humans. In addition, the present disclosure shows a specific strain of HCMV, HDu, is associated with several types of cancer. The identification cells harboring certain strains of HCMV, such as HDu, will provide a novel mechanism to identify cells that are at risk for undergoing oncogenesis. Novel strategies for detecting HCMV are also disclosed.
Claims40
A method for detecting the presence of a HCMV in a tissue sample, the method comprising the steps of:
- a. providing said tissue sample suspected of containing HCMV from said subject, said tissue sample being embedded in a paraffin matrix, and mounting said tissue sample to a transparent support;
- b. de-paraffinizing said tissue sample;
- c. subjecting said tissue sample an epitope conditioning procedure to reduce epitope variability in said tissue sample;
- d. subjecting said tissue sample to an antigen retrieval procedure,
- e. contacting said tissue sample with at least one antibody capable of binding to at least one epitope of HCMV to form an antibody-epitope complex, under conditions suitable for binding of said antibody with said epitope;
- f. detecting said antibody epitope complex.
A method of determining if a human subject is at risk for a disease correlated with the presence of a HCMV infection, said method comprising the steps of:
- a. providing a tissue sample suspected of containing HCMV from said subject;
- b. determining if HCMV is present in said tissue sample.
An immunohistochemistry kit for determining the presence of a HCMV present at a low copy number in a tissue sample, said kit comprising:
- a. epitope conditioning reagents, said epitope conditioning reagents comprising neutral buffered formalin (10%), and at least one enzyme for digestion of said tissue sample;
- b. antigen recovery reagents, said antigen recovery reagents comprising citra buffer and distilled water;
- c. HCMV control tissue reagent, said control tissue reagent comprising at least one of a positive control HCMV tissue and a negative control HCMV tissue;
- d. at least one primary antibody specific for at least one epitope of HCMV;
- e. at least one negative control antibody;
- f. at least one secondary antibody capable of interacting with said primary and negative control antibodies;
- and
- g. supplementary and signal producing reagents, said supplementary and signal producing reagents comprising at least one of a blocking reagent, a labeling reagent capable of interacting with the secondary antibody, a chromogen capable of transformation by the labeling reagent to produce a detectable signal and a chromogen enhancer.
Dependencies are inferred from the claim text.